Team:BIOSINT Mexico/marketing

From 2012e.igem.org

(Difference between revisions)
 
(9 intermediate revisions not shown)
Line 130: Line 130:
                                 <p class="clr-1"><strong>SWOT analysis.</strong></p>
                                 <p class="clr-1"><strong>SWOT analysis.</strong></p>
                             </div>
                             </div>
-
                             <p>Kuxtal Biotech’s strengths are the knowledge of the customers necessities, which was acquired though the market analysis. The team consists of a strong group of specialists in biotechnology. It will provide excellent attention to the customers with follow-up programs for their projects and technical support. Because of the strategic location, the customers will have benefits as short delivery periods and avoid import duties for their synthesis products.</br></br>
+
                             <div style="text-align: center;"><img src="http://www.persoft.mx/biosint/images/SWOT.png"/></div>
-
The business opportunities will be the direct relation with the Biotechnology Department of the Tec de Monterrey. Kuxtal Biotech will also count with a group of external advisors in different areas thought the strategic alliance with Parque Tecnológico. Mexico has an unserved market which represents a huge opportunity to take advantage of.</br></br>
+
-
As a new company we will have weaknesses as lack of experience and branding. A threat might be the time delays on the approval of permits and documents.
+
-
</p>
+
                         </div>
                         </div>
               </div>
               </div>
Line 142: Line 139:
                                 <p class="clr-1"><strong>Sales forecast.</strong></p>
                                 <p class="clr-1"><strong>Sales forecast.</strong></p>
                             </div>
                             </div>
-
                             <p>To have sustainability as an Enterprise, Kuxtal´s goals for the first year are:</br></br>
+
                             <p>Kuxtal Biotech has potential customers throughout Mexico. They are mainly public institutions and university researchers.  
-
1.- Sale to individual researchers, universities with research departments, IGEM teams in México, and private researcher companies at least 200 primers per year.</br></br>
+
</br></br>The sales goal for the first year is $264,500 USD, which will be achieved within an estimate of 115000 primers sales.</p>
-
2.- Become the main supplier of academic kits for biological engineering of the Tecnológico de Monterrey Campuses: Querétaro, Guadalajara, Monterrey and Mexico City.</br></br>
+
-
3.- Become the supplier of at least 10 reasearch centers which investigation line requires gene synthesis.</br></br>
+
-
We are going to reach this goals throw the application of our market strategies.
+
-
</p>
+
                         </div>
                         </div>
Line 157: Line 150:
                                 <p class="clr-1"><strong>Target market strategy.</strong></p>
                                 <p class="clr-1"><strong>Target market strategy.</strong></p>
                             </div>
                             </div>
-
                             <p>The strategy to get in on the market will be going to symposiums and events that count with the presence of scientific community; also to figurate like a possible seller all the staff will be visiting the potential clients one by one. The contact with the customers can be by phone or email, with the objective to explain them the services and arrange treatment.</br></br>The main strategy to get in on the market will be going to symposiums and events that count with the presence of scientific community; also to figurate like a possible seller all the staff will be visiting the potential clients one by one. The contact with the customers can be by phone or email, with the objective to explain them the services and arrange treatment. Some ways of being in contact with clients are going to be:</br></br>
+
                             <p>- Public Institutions:</br>
-
• Directly by phone.</br></br>
+
a) Hospitals.</br>
-
• Internet and web site.</br></br>
+
b) Biomedical Research Centers.</br>
-
• Informative sessions in research centers as well as flyers poste don the anouncemente walls of Universities.</br></br>
+
c) Molecular Biology Laboratories.</br>
 +
d) Public Health Institutes.</br>
 +
e) Scientific Research Centers.</br></br>
 +
- University Researchers:</br>
 +
a) Public Universities.</br>
 +
b) Private Universities.</br>
 +
c) State Universities.</br>
 +
d) Autonomous Universities.</br></br>
 +
The main ways of being in contact with clients will be:</br>
 +
• Social media and website.</br>
 +
• Directly by phone.</br>
• Periodical visits to research centers and Universities to follow the projects of our clients in order to improve services and products for them.</p>
• Periodical visits to research centers and Universities to follow the projects of our clients in order to improve services and products for them.</p>
                         </div>
                         </div>
Line 172: Line 175:
                             </div>
                             </div>
                             <p>Kuxtal Biotech products will be both DNA and RNA oligos of different lengths, from primers to genes. The company will also provide a DNA sequencing service.</br></br>
                             <p>Kuxtal Biotech products will be both DNA and RNA oligos of different lengths, from primers to genes. The company will also provide a DNA sequencing service.</br></br>
-
It will guarantee the purity of the product, and if it does not meet the customer’s expectations their next purchase is free.</br></br>
 
To improve the quality of the final products, the methods of the company will have different certifications like ISO 9001:2008 on quality management systems, or NMX-EC-17025-IMNC-2006 on testing and calibration.</br></br>
To improve the quality of the final products, the methods of the company will have different certifications like ISO 9001:2008 on quality management systems, or NMX-EC-17025-IMNC-2006 on testing and calibration.</br></br>
The products will be delivered by mail throughout Mexico with all necessary precautions to ensure the order arrives in the condition it has left the laboratories.
The products will be delivered by mail throughout Mexico with all necessary precautions to ensure the order arrives in the condition it has left the laboratories.

Latest revision as of 01:29, 28 October 2012

Kuxtal

WHAT I CANNOT CREATE, I DO NOT UNDERSTAND RICHARD FEYNMAN’S
The 21st of September from 1551 the first University in North America was created.
It had the name of Real y Pontificia Universidad de México.

Marketing Plan

SWOT analysis.

Sales forecast.

Kuxtal Biotech has potential customers throughout Mexico. They are mainly public institutions and university researchers.

The sales goal for the first year is $264,500 USD, which will be achieved within an estimate of 115000 primers sales.

Target market strategy.

- Public Institutions:
a) Hospitals.
b) Biomedical Research Centers.
c) Molecular Biology Laboratories.
d) Public Health Institutes.
e) Scientific Research Centers.

- University Researchers:
a) Public Universities.
b) Private Universities.
c) State Universities.
d) Autonomous Universities.

The main ways of being in contact with clients will be:
• Social media and website.
• Directly by phone.
• Periodical visits to research centers and Universities to follow the projects of our clients in order to improve services and products for them.

Product strategy.

Kuxtal Biotech products will be both DNA and RNA oligos of different lengths, from primers to genes. The company will also provide a DNA sequencing service.

To improve the quality of the final products, the methods of the company will have different certifications like ISO 9001:2008 on quality management systems, or NMX-EC-17025-IMNC-2006 on testing and calibration.

The products will be delivered by mail throughout Mexico with all necessary precautions to ensure the order arrives in the condition it has left the laboratories.